baber/WOPTO huggingface dataset:
Patent CA-2332320-A1 (CA)
Inventor: IARTYM IGOR
IPC: H04L29/06
Filed: 2000-03-28
Abstract: The invention relates to mobility management of an Internet-type protocol traffic in a mobile communications system. At least one mobile exchange (DXT1, DXT2) in the mobile communications system is arranged to operate as a gateway which interfaces (router 1) the mobile communications system with external data networks. All the mobile exchanges (DXT1, DXT2) are arranged to use a user identity and a data equipment identity for identifying each mobile host and to use an identity of the mobile exchange currently serving the mobile host for defining the location of the mobile host. Each mobile host is dynamically or permanently allocated an IP address which is bound to the user identity, the data equipment identity and the location information of the respective mobile host. The use of the user identity and the data terminal identity provide a unique identification for the mobile host without any relation to the IP network. Also the location information is independent of the IP network. As a consequence, the mobile exchanges are able to route IP  datagrams having the allocated IP address from a gateway exchange (DXT1) to the serving exchange (DXT2) according to the location information and further to the respective mobile host according to the user identity and the data equipment identity bound to the IP address by using a mobile network specific routing method instead of mobile IP tunnelling.
Patent CA-2332667-A1 (CA)
Inventor: PICHLER AXEL
IPC: D21D5/16
Filed: 2001-01-29
Abstract: The invention refers to a flat or cylindrical screen, comprising rods and rod-bearing supporting elements. It is mainly characterised by the rods 1 having indentations 3 in the side walls which gear into inversely shaped recesses 4 in a supporting element 2. The invention also refers to a process for manufacturing a screen of this kind, characterised by the supporting elements 2 being bent open elastically and the rods 1 inserted, whereupon the supporting elements 2 spring back, encircle the rods 1 positively and form a screen mat.
Patent CA-2332714-A1 (CA)
Inventor: RIES KEVIN LYALL
IPC: B08B3/04
Filed: 1999-05-28
Abstract: A washer (10) for use in industrial applications which includes a housing (1 1) with a series of opposing spray nozzles (12, 13). Material to be processed entering the housing (11) is suspended between the opposing spray nozzles (1 2, 13) under fluid pressure and, by virtue of the angle of the opposing spray nozzles (12, 13), the material is both transported and cleaned on its way through the washer (10).
Patent CA-2333875-A1 (CA)
Title: Redox reversible bipyridyl osmium complex conjugates
Inventor: BUCK HARVEY B JR
IPC: G01N33/536
Filed: 1999-05-28
Abstract: Novel bipyridyl-osmium complex conjugates, their preparation, and their use in electrochemical assays are described. The redox reversible-osmium complexes can be prepared to exhibit unique reversible redox potentials and can thus be used in combination with other electroactive redox reversible species having redox potentials differing by at least 50 millivolts in electrochemical assays designed for use of multiple electroactive species in the same cell and in the same sample without interference between the two or more redox coupled conjugate systems.
Patent CA-2334550-A1 (CA)
Title: Method and compositions for the treatment or amelioration of female sexual dysfunction
Inventor: ADAMS MICHAEL A
IPC: A61K38/095
Filed: 1999-06-21
Abstract: The present invention provide a method of treating sexual dysfunction in a female, including the vasculogenic symptoms of delayed vaginal engorgement, diminished vaginal lubrication, pain or discomfort with intercourse (dyspareunia), diminished vaginal sensation, diminished clitoral orgasm, or of combating vaginal pain. The preferred compound for the method of this invention is apomorphine or one of its pharmaceutically acceptable salts, esters, or pro-drugs. Other compounds are selected from the group consisting of (i) bromocriptine, lisuride, methergolide, pergolide, pribidil, guinapril;  or (ii) 1-(2,5-dimethoxy-4-iodophenyl)-1-aminopropane, 5-methoxytryptamine, alpha-methyl-5-hydroxytryptamine, 2-methyl-5-hydroxytryptamine, N-acetyl-5-hydroxytryptamine, buspirone, sumatriptan; or (iii) isotocin, carbetocin, lysconopressin, deaminooxytocin, mesotocin, antocin, glumitocin, aspargitocin, valitocin, asvatocin, phasvatocin and seritocin. Alternatively, the apomorphine is co-administered with an apomorphine-potentiating amount of androgen, preferably testosterone either prior to, or concomitantly with, the administration of the apomorphine.
Patent CA-2334844-A1 (CA)
Title: Grenade launcher
Inventor: GABLOWSKI JURGEN
IPC: F41C27/06
Filed: 2000-05-31
Abstract: The invention relates to a mounted grenade launcher (13) for mounting beneath the barrel (3) of a rifle (1) and for firing a grenade cartridge (59). The pivotable grenade-launcher barrel (15) is mounted on a connecting piece (37) which surrounds said barrel to a certain extent and is thus rigid enough to prevent distortion by the stress from the shot. The grenade cartridges do not therefore become lodged in the grenade-launcher barrel, but can be removed or ejected easily. A removal or ejection device is preferably not necessary, the marksman simply grasps the empty cartridge shell with his fingers through recesses (61) at the rear of the grenade-launcher barrel (15) to remove the same.
Patent CA-2337495-A1 (CA)
Title: Melanocortin-4 receptor gene and use as a genetic marker for fat content, weight gain, and/or feed consumption of animals
Inventor: KIM KWAN SUK
IPC: C12N15/00
Filed: 1999-07-26
Abstract: Genetic markers in the porcine melanocortin-4 receptor (MC4R) gene are disclosed which are associated with fat content, growth rate, and feed consumption. Further, novel sequence data from regions of the gene are disclosed which may be used in a PCR test to screen for the presence of the marker. The genetic marker may be used to screen animals for breeding purposes which have the desired traits regarding fat content, growth rate, and feed consumption. Kits which take advantage of the PCR test are also disclosed.
Patent CA-2339950-A1 (CA)
Title: Device for holding paving blocks in position
Inventor: STROBL FREDERICK P JR
IPC: E01C11/22
Filed: 1999-08-27
Abstract: An elongated holding device (20) for holding paving blocks (86) in place. The device (20) has a pair of longitudinally spaced ends (36 & 38), an elongated vertical plate (24) having a front paving block contacting face (26) to define a border for a paved area, and a rear surface (28). The device (20) also includes a plurality of discrete, elongated footing elements (30) which are attached to a lower portion (28a) of the rear surface (28) of the plate (24). The footing elements (30) are spaced apart longitudinally of the plate (24) and extend rearwardly therefrom. A first connector structure (40) which includes an elongated, longitudinally extending tab (44) is located at one end of the device (20). The footing elements (30) each including a respective second connector structure (42) in the form of a tab receiving opening (54). Each of the tab receiving openings (54) is configured to receive and mate with the tab (44) of the first connector element (40) to thereby form a secure connection therebetween. The presence of a connector structure (42) at each footing element (30) increases the overall ability of the device to be adapted to fit the edging requirements and characteristics of paving areas of various sizes and shapes.
Patent CA-2340304-A1 (CA)
Title: Multicomponent vaccines
Inventor: PATTI JOSEPH M
IPC: A61K48/00
Filed: 1999-08-31
Abstract: Multicomponent vaccines are provided which aid in the prevention and treatment of staphylococcal infections and which include certain selected combinations of bacterial binding proteins or fragments thereof, or antibodies to those proteins or fragments. By careful selection of the proteins, fragments, or antibodies, a vaccine is provided that imparts protection against a broad spectrum of Staphylococcus bacterial strains and against proteins that are expressed at different stages of the logarithmic growth curve. In one embodiment of the invention, a composition is provided that includes at least a collogen binding protein or peptide (or an appropriate site directed mutated sequence thereof) such as CNA, or a protein or fragment with sufficiently high homology thereto, in combination with a fibrogen binding protein, preferably Clumping factor A ("ClfA") or Clumping factor B ("ClfB"), or a useful fragment thereof or a protein or fragment with sufficiently high homology thereto. The vaccines and products of the present invention are advantageous in that they respond to the urgent need of the medical community for a sustitute for small molecule antibiotics, which are rapidly losing effectiveness and provide effective combinations of the large number of known bacterial surface adhesins which can impart effective protection against a broad spectrum of bacterial infections.
Patent CA-2340318-A1 (CA)
Inventor: HAZAMA AKIHIRO
IPC: C07K16/18
Filed: 1999-02-23
Abstract: Hybridomas which are fused cell obtained from antibody-producing cells isolated from a mammal immunized with human cells and a myeloma cell line an d produce a monoclonal antibody inhibiting the liberation of human cell ATP; a nd the monoclonal antibody obtained by isolating and purifying from these hybridomas.
Patent CA-2340715-A1 (CA)
Title: Method of preparing a sterile article
Inventor: WANG QI
IPC: A61L2/08
Filed: 1999-07-29
Abstract: Disclosed is a method of preparing a sterile article. A poly(vinyl chloride) or polyvinylidene chloride polymer is produced that contains about 0.001 to about 5 wt.% of a metal complex having at least one anionic ligand that has at least one resonance structure in which the charge is localized on a carbon atom. An article is fabricated from the chlorinated polymer and the article is exposed to gamma radiation.
Patent CA-2341518-A1 (CA)
Inventor: SKALITER RAMI
IPC: A61K48/00
Filed: 1999-08-27
Abstract: There is provided the polynucleotide sequence of a gene whose expression is modulated by hypoxic conditions. Also provided is a polynucleotide sequence encoding a gene for protein 2-2-83. A pharmaceutical composition for modulating hypoxia and ischemia having an effective amount of a polynucleotide or protein having the nucleic acid sequence according to SEQ. ID NO. 1 and 2 or a functional analog thereof and a pharmaceutically acceptable carrier is also provided. There is provided a method of regulating hypoxic associated pathologies and tumorigenesis by administering an effective amount of a polynucleotide, proteins direct or indirect biologically active product of enzymatic activity of the protein, or inhibitors of direct or indirect biologically active product of enzymatic activity of the protein having a nucleic acid sequence from at least one from the group containing SEQ. ID NO.  1 and 2 and functional analogs thereof and a pharmaceutically acceptable carrier. A method of regulating hypoxic associated pathologies and tumorigenesis by inhibiting the enzymatic activity of the protein encoded by the polynucleotide sequences from at least one from the group containing SEQ  ID NO. 1 and 2 and functional analogs thereof is provided. A hypoxia response regulating is further provided. Neuroprotective and neurotrophic agents comprising a gene product of the polynucleotide sequence of 2-2-83 according to SEQ. ID NO. 1 and 2 and functional analogs thereof is also provided. There is provided a method of diagnosing the presence of a hypoxia associated pathology or tumorigenesis by screening for the reduced expression of the gene encoded by the nucleic acid sequence according to SEQ. ID NO. 1 and 2 and functional analogs thereof.
Patent CA-2344182-A1 (CA)
Title: Therapeutic agent for dermatitis
Inventor: YOSHII HARUO
IPC: A61K31/519
Filed: 2001-04-12
Abstract: The present invention provides a therapeutic agent for dermatitis, particularly a therapeutic agent for atopic dermatitis, having high safety and showing little adverse reaction such as steroidal agent.      The present invention relates to a therapeutic agent for dermatitis, particularly a therapeutic agent for atopic dermatitis, containing a compound represented by the following formula (I) or a pharmaceutically acceptable salt or hydrate thereof as an effective ingredient.   (see formula I) (In the formula, R is hydrogen or halogen.) The therapeutic agent for dermatitis according to the present invention significantly and dose-dependently suppressed the antigen-induced swelling reaction in a mouse ear recognized as an animal model for atopic dermatitis. Also, the agent suppressed the antigen-induced flare reaction of mice occurred with the swelling reaction. In addition, the adverse reaction to the skin was not observed. The therapeutic agent for dermatitis of this invention is, therefore, very useful as a drug for atopic dermatitis with high safety.
Patent CA-2347636-A1 (CA)
Title: Rotatable flap folder
Inventor: ROBINSON GLENN
IPC: B65B7/20
Filed: 1999-10-21
Abstract: A cylindrical segment having a longitudinal axis has a helical edge which serves as a static flap folding edge for a carton in translatory motion with respect to the cylindrical segment. The cylindrical segment is reciprocally rotatable about an axis such that when the cylindrical segment rotates the helical edge progressively engages and folds a flap of a carton disposed at the helical edge.
Patent CA-2347978-A1 (CA)
Title: Methode de depot d'une poudre seche et distributeur
Inventor: CHRAI SUGGY S
IPC: A61M15/00
Filed: 1999-10-25
Abstract: La présente invention concerne une poudre sèche, par exemple un médicament destiné à un inhalateur, qui se compose de particules oblongues dont l'allongement est suffisant pour que leurs extrémités adhèrent par dépôt électrostatique à un substrat constitué de préférence d'une feuille de matériau métallique ou non métallique, et pour qu'une pluralité de ces particules s'alignent bout à bout avec leur axe principal perpendiculaire au substrat. Les particules selon l'invention forment un dépôt dont la faible densité et le vide relativement élevé réduisent les forces d'attraction entre elles. Ces particules ont moins tendance à s'agglomérer les unes aux autres et à se coller au substrat, ce qui facilite la libération du médicament en poudre dans l'inhalateur. Des doses de médicament situées dans une poche du substrat sont recouvertes d'un film protecteur. L'invention concerne un substrat d'inhalateur avec dose de médicament et un inhalateur.
Patent CA-2348198-A1 (CA)
Title: Auger for combine header
Inventor: LAUER DAVID M
IPC: A01D61/00
Filed: 2001-05-18
Abstract: An auger for a combine includes a central tube having an outer cylindrical surface and having a first diameter; flighting extends from the outer surface of the central tube. The flighting has an outer edge. An auger diameter is defined as the diameter extending from a top edge of the flighting to the bottom edge of the flighting. The first diameter is approximately 25 percent of the outer diameter.
Patent CA-2349428-A1 (CA)
Title: Alpha 1,2-fucosyltransferase from helicobacter pylori
Inventor: PALCIC MONICA MARIJA
IPC: G01N33/569
Filed: 1999-11-03
Abstract: A bacterial .alpha. 1,2 fucosyltransferase gene and deduced amino acid sequence is provided. The gene is useful for preparing .alpha. 1,2-fucosyltransferase polypeptide, and active fragment thereof, which can be used in the production of oligosaccharides such as Lewis X, Lewis Y, Lewis B and H type 1, which are structurally similar to certain tumor-associated carbohydrate antigens found in mammals. These product glycoconjugates also have research and diagnostic utility in the development of assays to detect mammalian tumors.
Patent CA-2350111-A1 (CA)
Inventor: DUAN LINGXUN
IPC: C12Q1/68
Filed: 1999-11-12
Abstract: The present invention relates to a process for producing antibodies to an antigen in an avian species using polynucleotide vaccination. The present invention also relates to a process for determining the proteomics profile o f a set of pre-selected DNA sequences isolated from a bio-sample, preferably t he proteomics profile of a human cDNA library. The present invention further relates to a process for identifying physiologically distinguishable markers  associated with a physiologically abnormal bio-sample.
Patent CA-2351417-A1 (CA)
Inventor: KAWAI EIJI
IPC: H01L23/58
Filed: 1999-11-19
Abstract: L'invention concerne un microcircuit présentant un rapport dimension/échelle optimal et exempt de rétrécissements avant contact. Cette puce est composée d'un substrat (1) comprenant des modules (6, 7, 8) et une première et une seconde série de bornes (2, 4) d'E/S permettant le couplage des signaux avec le module (6, 7, 8). La première série de bornes (2) d'E/S permet le couplage des signaux de commande direction et en provenance du module (6, 7, 8) tandis que la seconde série de bornes (4) d'E/S est utilisée pour tester les modules (6, 7, 8). Les premières bornes (2) d'E/S sont disposées le long du bord du substrat (1), et les secondes bornes d'E/S ainsi que les modules (6, 7, 9) sont placés à l'intérieur des premières bornes (2) d'E/S sur le substrat. Les premières bornes (2) d'E/S sont connectées à des cosses (12) de connexion au moyen de fils (14) de liaison, et les secondes bornes (4) d'E/S ne sont pas connectées aux cosses (12) de connexion.
Patent CA-2353648-A1 (CA)
Title: High-power well logging method and apparatus
Inventor: BAIRD GARY K
IPC: E21B47/12
Filed: 1999-11-19
Abstract: A system and method for safely and economically providing up to 1800 watts to downhole equipment is shown in the figure.      In one embodiment, the system uses a standard multiconductor logging cable (20) which supports orthogonal signal transmission modes on circumferentially spaced insulated conductors (1, 2, 3, 6, 7). A high-powered power source on the surface (Ml, M2.      M3, M4) is coupled to the insulated conductors in the cable to drive a power signal on the lowest impedance signal transmission mode. Safety may be enhanced by the addition of a reliable current imbalance detector configured to shut down all power source when currents in the insulated conductors do not add to zero. The system may further include multiple power sources operating on different independent signal transmission modes, and may also include multiple telemetry channels which share the power transmission modes via multiplexing.
Patent CA-2355869-A1 (CA)
Title: Semiconducting polymer field effect transistor
Inventor: BERNIUS MARK T
IPC: H01L51/00
Filed: 1999-12-22
Abstract: A field effect transistor is made of five parts. The first part is an insulator layer, the insulator layer being an electrical insulator such as silica, the insulator layer having a first side and a second side. The second part is a gate, the gate being an electrical conductor such as silver, the gate being positioned on the first side of the insulator layer. The third part is a semiconductor layer, the semiconductor layer including a polymer, at least ten weight percent of the monomer units of the polymer being a 9-substituted fluorene unit and/or a 9,9-substituted fluorene unit, the semiconductor layer having a first side, a second side, a first end and a second end, the second side of the semiconductor layer being on the second side of the insulator layer. The fourth part is a source, the source being an electrical conductor such as silver, the source being in electrical contact with the first end of the semiconductor layer. The fifth part is a drain, the drain being an electrical conductor such as silver, the drain being in electrical contact with the second end of the semiconductor layer. A negative voltage bias applied to the gate causes the formation of a conduction channel in the semiconductor layer from the source to the drain. On the other hand, a positive bias applied to the gate causes the formation of an electron conducting channel in the semiconductor layer.
Patent CA-2357048-A1 (CA)
Title: Method and apparatus of processing semistructured textual data
Inventor: ETZOLD THURE
IPC: G06F17/27
Filed: 1999-12-23
Abstract: A method of processing semistructured data, in particular semistructured textual data, to output data which is in accordance with a predetermined structure, wherein said semistructured data is structured into one or more elements according to a given syntax, the actual content of the syntax elements being variable and being called a token, said method comprising:  extracting by means of an extractor ("parser") from said semistructured data one or more tokens, said parser being capable of returning at least one token in response to a respective specific command identifying the requested token by a token identifier, wherein said method further comprises: providing a sequence of commands and an associated data structure definition, both together being called a loader, said loader comprising the commands necessary to cause said parser to return the one or more tokens to be extracted; causing by said sequence of commands of said loader said parser to extract said one or more tokens from said semistructured data and further converting said extracted tokens into said predetermined data structure defined by said associated structure definition.
Patent CA-2357121-A1 (CA)
Title: Sanitary absorbent article
Inventor: GUARAGNA FLAVIA GUIMARAES
IPC: A61F/
Filed: 2001-09-11
Abstract: A sanitary napkin(10) having a central absorbent pad (12), a flap (24,24') extending laterally outward from each longitudinal side edge (90,90') and two preferential bending axes (30,30'), each axis being inward from and adjacent to a respective longitudinal side edge (90,90') and extending obliquely with respect to the longitudinal centerline (80), the axes converging towards the longitudinal centerline (80) in a distal end of the central absorbent pad (12).
Patent CA-2360594-A1 (CA)
Title: System for imaging a recording film
Inventor: LEWIS DAVID F
IPC: G03F7/025
Filed: 1991-09-16
Abstract: The invention relates to the exposure of a recording film to an image transmitting device and to a thermochromic polyacetylenic recording film comprising, as an imageable medium, a supported, imageable crystalline polyacetylene monomer layer in contact with an imageable polyacetylene polymer in a mole ratio of between about 1:1 and about 1000:1 which medium additionally can contain an energy absorbing, heat transferring agent having an optical absorbance at a wavelength similar to that of the image transmitting device.
Patent CA-2361375-A1 (CA)
Inventor: SIU TA-YAN
IPC: H04W4/90
Filed: 2000-02-09
Abstract: When an incoming call is received or an outgoing call is placed, a phone number associated with the call is identified. The phone number is compared to a set of phone book entries corresponding to subscriber-designated phone entries and special phone book entries. If the phone number is identified as corresponding to a special phone book entry, call processing continues according to a field type designated by the selected phone book entry.
Patent CA-2361848-A1 (CA)
Title: Novel lactam inhibitors of matrix metalloproteinases, tnf-.alpha., and aggrecanase
Inventor: DUAN JINGWU
IPC: C07D401/12
Filed: 2000-03-30
Abstract: The present application describes novel lactams and derivatives thereof of formula (I) or pharmaceutically acceptable salt forms thereof, wherein ring B  is a 4-8 membered lactam containing from 0-3 additional heteroatoms selected from N, O, and S, which are useful as inhibitors of matrix metalloproteinases, TNF-.alpha., and aggrecanase.